Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8

Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh enzim CYP3A4 dan CYP2C8. Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of type 2 diabetes mellitus. Repaglinide is...

Full description

Saved in:
Bibliographic Details
Main Author: Abu Bakar, Ruzilawati
Format: Thesis
Language:English
Published: 2008
Subjects:
Online Access:http://eprints.usm.my/29661/1/Population_pharmacokinetics_of_repaglinide_in_heal_thy_subjects_and_genetic_pol_ymorphisms_of_CYP3A4_AND_CYP2CB___________________________f.pdf
http://eprints.usm.my/29661/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Sains Malaysia
Language: English
id my.usm.eprints.29661
record_format eprints
spelling my.usm.eprints.29661 http://eprints.usm.my/29661/ Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8 Abu Bakar, Ruzilawati RS Pharmacy and materia medica Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh enzim CYP3A4 dan CYP2C8. Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of type 2 diabetes mellitus. Repaglinide is mainly metabolised in the liver by CYP3A4 and CYP2C8 enzymes. 2008-10 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/29661/1/Population_pharmacokinetics_of_repaglinide_in_heal_thy_subjects_and_genetic_pol_ymorphisms_of_CYP3A4_AND_CYP2CB___________________________f.pdf Abu Bakar, Ruzilawati (2008) Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8. PhD thesis, USM.
institution Universiti Sains Malaysia
building Hamzah Sendut Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Sains Malaysia
content_source USM Institutional Repository
url_provider http://eprints.usm.my/
language English
topic RS Pharmacy and materia medica
spellingShingle RS Pharmacy and materia medica
Abu Bakar, Ruzilawati
Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
description Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh enzim CYP3A4 dan CYP2C8. Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of type 2 diabetes mellitus. Repaglinide is mainly metabolised in the liver by CYP3A4 and CYP2C8 enzymes.
format Thesis
author Abu Bakar, Ruzilawati
author_facet Abu Bakar, Ruzilawati
author_sort Abu Bakar, Ruzilawati
title Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
title_short Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
title_full Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
title_fullStr Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
title_full_unstemmed Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
title_sort population pharmacokinetics of repaglinide in healthy subjects and genetic polymorphisms of cyp3a4 and cyp2c8
publishDate 2008
url http://eprints.usm.my/29661/1/Population_pharmacokinetics_of_repaglinide_in_heal_thy_subjects_and_genetic_pol_ymorphisms_of_CYP3A4_AND_CYP2CB___________________________f.pdf
http://eprints.usm.my/29661/
_version_ 1643706958438465536